ASX:ACL Australian Clinical Labs (ACL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Australian Clinical Labs Stock (ASX:ACL) 30 days 90 days 365 days Advanced Chart Get ACL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationA$728.27 millionP/E Ratio30.38Dividend Yield3.28%Price TargetN/AConsensus RatingN/A Company Overview Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia. Read More Receive ACL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address ACL Stock News HeadlinesAustralian Clinical Labs Appoints Stephen Roche as New Board ChairJune 19, 2025 | tipranks.comAustralian Clinical Labs Updates on Buy-Back ProgramMay 29, 2025 | tipranks.comTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.July 28 at 2:00 AM | Porter & Company (Ad)Australian Clinical Labs Limited (ASX:ACL) Shares Could Be 44% Below Their Intrinsic Value EstimateMay 18, 2025 | finance.yahoo.comLeadership Transition at Australian Clinical LabsApril 15, 2025 | tipranks.comAustralian Clinical Labs Updates Share Buy-Back ProgressApril 2, 2025 | tipranks.comAustralian Clinical Labs Limited (ASX:ACL) is a favorite amongst institutional investors who own 62%March 28, 2025 | finance.yahoo.comAustralian Clinical Labs Sees Change in Substantial HoldersMarch 3, 2025 | tipranks.comSee More Headlines ACL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Australian Clinical Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), Coles Group (COL) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:ACL CIKN/A Webwww.clinicallabs.com.au Phone61 3 9538 6777FaxN/AEmployees5,115Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.12 Trailing P/E Ratio30.38 Forward P/E RatioN/A P/E Growth-0.36Net IncomeA$23.93 million Net Margins3.45% Pretax MarginN/A Return on Equity13.98% Return on Assets6.67% Debt Debt-to-Equity Ratio174.00 Current Ratio0.64 Quick Ratio0.53 Sales & Book Value Annual SalesA$696.37 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.89 per share Price / BookN/AMiscellaneous Outstanding Shares201,830,000Free FloatN/AMarket CapA$728.27 million OptionableNot Optionable Beta1.18 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (ASX:ACL) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredThe Dollar’s Crashing—What Are You Doing About It?The U.S. dollar is down 10.8%—its steepest drop since 1973. As global confidence in the dollar fades, centr...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Clinical Labs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Australian Clinical Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.